Biological E. Ltd – The firm started phase I and phase II trials of its vaccine candidate in November. It is being developed in partnership with the #Baylor College of Medicine in Houston and Dynavax Technologies.

 

https://uk.reuters.com/article/health-coronavirus-india-factbox/factbox-indian-pharma-industrys-covid-19-vaccine-plans-idUKKBN28K10L

The world’s largest producer of vaccines prepares for a massive response to the coronavirus pandemic

India is focusing on affordable vaccines instead of the expensive messenger RNA shots of #Pfizer Inc and #Moderna Inc #mRNA

[….]

Biological E. Ltd – The firm started phase I and phase II trials of its vaccine candidate in November.

It is being developed in partnership with the #Baylor College of Medicine in Houston and Dynavax Technologies.

The Hyderabad-based company’s trial will test two doses of the vaccine in about 360 healthy subjects and it expects results by February.

+++

https://www.motherjones.com/coronavirus-updates/2020/11/these-researchers-have-developed-an-inexpensive-low-tech-covid-vaccine/

#Pfizer and #Moderna

Both vaccines utilize a novel technology that harnesses the RNA messenger, snippets of genetic code that exist in the body that can be used to tell the immune system to produce antibodies that attack the virus itself. (What could go wrong?)

[Waiting for the #Baylor vaccine or another “recombinant proteins” vaccine]

#SARSCoV2